<?xml version="1.0" encoding="UTF-8"?>

<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">

 

<channel>

<ttl>60</ttl>

<title>Clinical Care Options Hepatitis - Video Podcast</title>

<link>http://clinicaloptions.com/oncology.aspx</link>

<language>en-us</language>

<copyright>&#x2117; &amp; &#xA9; 2006 Clinical Care Options</copyright>

<itunes:subtitle>CCO is your best source for the newest HBV and HCV treatment data.</itunes:subtitle>

<itunes:author>Clinical Care Options</itunes:author>

<itunes:summary>Video education programs and slide presentations for hepatitis treaters</itunes:summary>

<itunes:owner>

<itunes:name>Clinical Care Options Oncology Video Podcast</itunes:name>

<itunes:email>vkeane@clinicaloptions.com</itunes:email>

</itunes:owner>

<itunes:image href="http://images.clinicaloptions.com/images/podcast/HEP_podcast_logo_video.jpg" />

<itunes:category text="Science &amp; Medicine">
	<itunes:category text="Medicine" />
	</itunes:category>

 
 
 <item>
            
            <title>CCO Animation - Life Cycle of Hepatitis C Virus</title>
            
            <itunes:author>Clinical Care Options</itunes:author>
            
            <itunes:subtitle>This 3D animation is availble for use in your talks.</itunes:subtitle>
            
            <itunes:summary>This animation presents the steps by which the hepatitis C virus infects and replicates in the cell. This animation and others are available for use offline from the CCO Download Library.
 
 
 </itunes:summary>
            
            <enclosure url="http://clinicaloptions.com/hep_podcast_video_ani_hcv.mp4" length="15302166" type="video/mp4" />
            
            
            
            <guid>http://clinicaloptions.com/hep_podcast_video_ani_hcv.mp4</guid>
            
            <pubDate>Tue, 12 Sep 2006 17:00:00 GMT</pubDate>
            
            <itunes:duration>3:17</itunes:duration>
            
            <itunes:keywords>hepatitis, HCV, Clinical Care Options</itunes:keywords>
           
  </item>
 
 
 <item>
          
          <title>CCO Animation - Sinusoidal Changes in Liver Fibrogenesis</title>
          
          <itunes:author>Clinical Care Options</itunes:author>
          
          <itunes:subtitle>This 3D animation is availble for use in your talks.</itunes:subtitle>
          
          <itunes:summary>Watch this CCO animation then go online and download it for use in your talks.</itunes:summary>
          
          <enclosure url="http://clinicaloptions.com/hep_podcast_video_ani_fibro.mp4" length="5276769" type="video/mp4" />
          
          
          
          <guid>http://clinicaloptions.com/hep_podcast_video_ani_fibro.mp4</guid>
          
          <pubDate>Fri, 28 Apr 2006 17:00:00 GMT</pubDate>
          
          <itunes:duration>1:19</itunes:duration>
          
          <itunes:keywords>hepatitis, fibrosis, liver</itunes:keywords>
         
  </item>
 
 

  <item>
         
         <title>Mitchell L. Shiffman, MD - HCV Management: Facing New Challenges</title>
         
         <itunes:author>Clinical Care Options</itunes:author>
         
         <itunes:subtitle>A CCO Expert Recap of HCV data from the meeting in San Francisco.</itunes:subtitle>
         
         <itunes:summary>Mitchell L. Shiffman, MD, review slides of key data from the San Francisco meeting.</itunes:summary>
         
         <enclosure url="http://clinicaloptions.com/hep_podcast_video_er_sf05.mp4" length="51500406" type="video/mp4" />
         
         
         
         <guid>http://clinicaloptions.com/hep_podcast_video_er_sf05.mp4</guid>
         
         <pubDate>Fri, 28 Apr 2006 17:00:00 GMT</pubDate>
         
         <itunes:duration>46:28</itunes:duration>
         
         <itunes:keywords>hepatitis, HCV, Shiffman</itunes:keywords>
        
  </item>

 
<item>
   
   <title>Robert G. Gish, MD - Expert Highlight: Approved HBV Agents</title>
   
   <itunes:author>Clinical Care Options</itunes:author>
   
   <itunes:subtitle>Independent Video highlights from the AASLD 2008 meeting in San Francisco</itunes:subtitle>
   
   <itunes:summary>Robert G. Gish, MD, reviews data from AASLD 2008 on frontline  hepatitis B treatment options with approved agents and predicting response based on patient and viral characteristics.</itunes:summary>
   
   <enclosure url="http://clinicaloptions.com/hep_podcast_video_sanfrancisco2008_Gish.m4v" length="134455296" type="video/m4v" />
   
   
   
   <guid>http://clinicaloptions.com/hep_podcast_video_sanfrancisco2008_Gish.m4v</guid>
   
   <pubDate>Mon, 24 Nov 2008 17:00:00 GMT</pubDate>
   
   <itunes:duration>11:08</itunes:duration>
   
   <itunes:keywords>hepatitis, AASLD, Gish</itunes:keywords>
   
 </item>

<item>
   
   <title>Gregory T. Everson, MD, FACP - Expert Highlight: Approved HCV Agents</title>
   
   <itunes:author>Clinical Care Options</itunes:author>
   
   <itunes:subtitle>Independent Video highlights from the AASLD 2008 meeting in San Francisco</itunes:subtitle>
   
   <itunes:summary>Gregory T. Everson, MD, FACP, discusses data from AASLD 2008 on strategies for improving hepatitis C treatment response with approved agents and predicting response based on various possible responses and assays.</itunes:summary>
   
   <enclosure url="http://clinicaloptions.com/hep_podcast_video_sanfrancisco2008_Everson.m4v" length="46755840" type="video/m4v" />
   
   
   
   <guid>http://clinicaloptions.com/hep_podcast_video_sanfrancisco2008_Everson.m4v</guid>
   
   <pubDate>Mon, 24 Nov 2008 17:00:00 GMT</pubDate>
   
   <itunes:duration>3:55</itunes:duration>
   
   <itunes:keywords>hepatitis, AASLD, Everson</itunes:keywords>
   
 </item>

</channel>

</rss>

